{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:51:57Z","timestamp":1773294717513,"version":"3.50.1"},"reference-count":59,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T00:00:00Z","timestamp":1269475200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>Gracious BL, Chirieac MC, Costescu S, Finucane TL, Youngstrom EA, Hibbeln JR. Randomized, placebo\u2010controlled trial of flax oil in pediatric bipolar disorder.\u2028Bipolar Disord 2010: 12: 142\u2013154. \u00a9 2010 The Authors.\u2028Journal compilation \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> This clinical trial evaluated whether supplementation with flax oil, containing the omega\u20103 fatty acid \u03b1\u2010linolenic acid (\u03b1\u2010LNA), safely reduced symptom severity in youth with bipolar disorder.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Children and adolescents aged 6\u201317\u2003years with symptomatic bipolar I or bipolar II disorder (n\u2003=\u200351), manic, hypomanic, mixed, or depressed, were randomized to either flax oil capsules containing 550\u2003mg \u03b1\u2010LNA per 1\u2003gram or an olive oil placebo adjunctively or as monotherapy. Doses were titrated to 12 capsules per day as tolerated over 16\u2003weeks. Primary outcomes included changes in the Young Mania Rating Scale, Child Depression Rating Scale\u2010Revised, and Clinical Global Impressions\u2010Bipolar ratings using Kaplan\u2010Meier survival analyses.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> There were no significant differences in primary outcome measures when compared by treatment assignment. However, clinician\u2010rated Global Symptom Severity was negatively correlated with final serum omega\u20103 fatty acid compositions: %\u03b1\u2010LNA (<jats:italic>r\u2003<\/jats:italic>=\u2003\u22120.45, p\u2003&lt;\u20030.007), % eicosapentaenoic acid (EPA) (<jats:italic>r<\/jats:italic>\u2003=\u2003\u22120.47, p\u2003&lt;\u20030.005); and positively correlated with final arachidonic acid (AA) (<jats:italic>r\u2003=\u2003<\/jats:italic>0.36, p\u2003&lt;\u20030.05) and docosapentaenoic acid (DPA) n\u20106 (<jats:italic>r\u2003=\u2003<\/jats:italic>0.48, p\u2003&lt;\u20030.004). The mean duration of treatment for \u03b1\u2010LNA was 11.8\u2003weeks versus 8\u2003weeks for placebo; however, the longer treatment duration for \u03b1\u2010LNA was not significant after controlling for baseline variables. Subjects discontinued the study for continued depressive symptoms.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Studies of essential fatty acid supplementation are feasible and well tolerated in the pediatric population. Although flax oil may decrease severity of illness in children and adolescents with bipolar disorder who have meaningful increases in serum EPA percent levels and\/or decreased AA and DPA n\u20106 levels, individual variations in conversion of \u03b1\u2010LNA to EPA and docosahexaenoic acid as well as dosing burden favor the use of fish oil both for clinical trials and clinical practice. Additionally, future research should focus on adherence and analysis of outcome based on changes in essential fatty acid tissue compositions, as opposed to group randomization alone.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2010.00799.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T11:55:24Z","timestamp":1269518124000},"page":"142-154","source":"Crossref","is-referenced-by-count":81,"title":["Randomized, placebo\u2010controlled trial of flax oil in pediatric bipolar disorder"],"prefix":"10.1111","volume":"12","author":[{"given":"Barbara L","family":"Gracious","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina C","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Costescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L","family":"Finucane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A","family":"Youngstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R","family":"Hibbeln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.58"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1217"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.6.969"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000242240.69678.c4"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2008.11.004"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-001-0805-6"},{"key":"e_1_2_7_8_2","first-page":"57","article-title":"The role of omega\u20103 fatty acids in mood disorders","volume":"9","author":"Stahl LA","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.6.1483S"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000192992"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.12.2222"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00166-3"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00206-0"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(95)00092-5"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02637069"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00387.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(99)00014-1"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2003.10.005"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602413"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2002.0435"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2007.08.021"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/pr800188y"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31815aaa42"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.5.1156"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.1.40"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-008-3224-z"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.028"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.026"},{"key":"e_1_2_7_29_2","first-page":"837","article-title":"The major psychoses and neuroses as omega\u20103 essential fatty acid deficiency syndrome: substrate pellagra","volume":"16","author":"Rudin DO","year":"1981","journal-title":"Biol Psychiatry"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.407"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0608"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-4-6"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.1.46"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.03.056"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2164"},{"key":"e_1_2_7_36_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","article-title":"Omega\u20103 treatment of childhood depression: a controlled double\u2010blind pilot study","volume":"163","author":"Nemets H","year":"2006","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2006.11.006"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0712"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(97)00123-6"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.64.4.442"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199707000-00021"},{"key":"e_1_2_7_43_2","first-page":"199","article-title":"Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS","volume":"4","author":"Spencer EK","year":"1994","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_7_44_2","first-page":"508","volume-title":"Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines","author":"Klein RG","year":"1994"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.6.730"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3170"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.3758\/BF03193146"},{"key":"e_1_2_7_48_2","volume-title":"Power and Precision (Version 2.1)","author":"Borenstein M","year":"2001"},{"key":"e_1_2_7_49_2","volume-title":"Evidence\u2010Based Medicine: How to Practice and Teach EBM","author":"Sackett DL","year":"2000"},{"key":"e_1_2_7_50_2","volume-title":"Statistical Rules of Thumb","author":"Van Belle G","year":"2002"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529620"},{"key":"e_1_2_7_52_2","volume-title":"Users\u2019 Guides to the Medical Literature","author":"Guyatt GH","year":"2002"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000155981.83865.ea"},{"key":"e_1_2_7_54_2","volume-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"Raudenbush SW","year":"2002"},{"key":"e_1_2_7_55_2","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm S","year":"1979","journal-title":"Scand J Stat"},{"key":"e_1_2_7_56_2","volume-title":"A Primer on Regression Artifacts","author":"Campbell DT","year":"1999"},{"key":"e_1_2_7_57_2","first-page":"159","article-title":"Can adults adequately convert alpha\u2010linolenic acid (18:3n\u20103) to eicosapentaenoic acid (20:5n\u20103) and docosahexaenoic acid (22:6n\u20103)?","volume":"68","author":"Gerster H","year":"1998","journal-title":"Intern J Vit Nutr Res"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl117"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1993.10718342"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.6.1163"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2010.00799.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2010.00799.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:09:16Z","timestamp":1698746956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2010.00799.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1399-5618.2010.00799.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00799.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}